Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Health Technology Group Holding Co (OTCPK:CHBOF) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
China Health Technology Group Holding Co Forward PE Ratio Related Terms
China Health Technology Group Holding Co Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co Forward PE Ratio Chart
China Health Technology Group Holding Co Annual Data
Trend
Forward PE Ratio
China Health Technology Group Holding Co Semi-Annual Data
Forward PE Ratio
CHBOF vs SSD, UFPI, BCC: Forward PE Ratio Comparison
For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Technology Group Holding Co Forward PE Ratio vs Forest Products Industry
For the Forest Products industry and Basic Materials sector, China Health Technology Group Holding Co's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where China Health Technology Group Holding Co's Forward PE Ratio falls into.
China Health Technology Group Holding Co Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
China Health Technology Group Holding Co (CHBOF) has a Forward PE Ratio of 0.00 as of Jul. 22, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on China Health Technology Group Holding Co and its competitors. According to the industry distribution chart, China Health Technology Group Holding Co ranks #999999 out of 84 companies in the Forest Products industry.
Is China Health Technology Group Holding Co's Forward PE Ratio too high?
China Health Technology Group Holding Co's current Forward PE Ratio is 0.00. Based on the distribution chart, China Health Technology Group Holding Co ranks #999999 out of 84 companies in the Forest Products industry, which is in the bottom quartile relative to peers. Overall, China Health Technology Group Holding Co has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's Forward PE Ratio compare to SSD and UFPI?
According to the Forest Products industry distribution chart, China Health Technology Group Holding Co ranks #999999 out of 84 companies for Forward PE Ratio. This places China Health Technology Group Holding Co in the lower half of its industry. The industry median Forward PE Ratio is 15.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Forest Products company?
The median Forward PE Ratio among Forest Products companies is 15.62, based on 84 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on China Health Technology Group Holding Co and its competitors. For the Forest Products industry, the median Forward PE Ratio is 15.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Technology Group Holding Co's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current Forward PE Ratio of 0.00. The stock's GF Value™ is $0.05, compared to a current price of $0.03 — trading 34.1% below its estimated fair value. The current Forward PE Ratio is 0.00. China Health Technology Group Holding Co's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current Forward PE Ratio is 0.00 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued.
The current stock price of $0.03 is trading 34.1% below its estimated GF Value™ of $0.05.
Key valuation signals for CHBOF:
Forward PE Ratio: 0.00
GF Value™: $0.05 vs. price of $0.03 (34.1% below fair value)
No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Technology Group Holding Co Business Description
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
27GF Score
Get the complete analysis for CHBOF
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHBOF has been successfully added to your 
